Skip to main content
. 2021 Aug 10;16(8):e0255796. doi: 10.1371/journal.pone.0255796

Fig 3. Analysis of classes of antibody responses to RBD in serum samples of acute and convalescent-phase COVID-19 patients, healthy donors and patients with other infections.

Fig 3